PUBLIC CONTRACT · 2025
4180372/2026-aq. Central P1330 - Pembrolizumab 100 mg (25 mg/ml frs 4 ml) sol inj
- Contract value
- €51,150.00
- Signed on
- 20 August 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 14022555PUBLISHED SUBJECT
4180372/2026-AQ. CENTRAL P1330 - PEMBROLIZUMAB 100 MG (25 MG/ML FRS 4 ML) SOL INJ
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MERCK SHARP & DOHME, LDA · Tax ID 500191360
Values and timeline
- Contract price
- €51,150.00
- Procedure base price
- €51,150.00
- Total effective price
- €51,150.00
- Publication date
- 11 March 2026
- Award date
- 20 August 2025
- Signing date
- 20 August 2025
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 27/2015/A, de 29.12
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 10047935
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.